[1] Lutz M P,
Zalcberg J R,
Glynne-Jones R,
et al.
Second St.
Gallen European Organisation for Research and Treatment of Cancer Gastrointestinal Cancer Conference: consensus recommendations on controversial issues in the primary treatment of rectal cancer.
Eur J Cancer,
2016,
63:11-24.
[2] Habr-Gama A,
Perez R O,
Nadalin W,
et al.
Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results.
Ann Surg,
2004,
240:711-717; discussion 717-718.
[3] Maas M,
Beets-Tan R G,
Lambregts D M,
et al.
Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer.
J Clin Oncol,
2011,
29:4633-4640.
[4] Patel U B,
Taylor F,
Blomqvist L,
et al.
Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience.
J Clin Oncol,
2011,
29:3753-3760.
[5] Siddiqui M R,
Bhoday J,
Battersby N J,
et al.
Defining response to radiotherapy in rectal cancer using magnetic resonance imaging and histopathological scales.
World J Gastroenterol,
2016,
22:8414-8434.
[6] Shihab O C,
Taylor F,
Salerno G,
et al.
MRI predictive factors for long-term outcomes of low rectal tumours.
Ann Surg Oncol,
2011,
18:3278-3284.
[7] Xia C C,
Liu X,
Peng W L,
et al.
Readout-segmented echo-planar imaging improves the image quality of diffusion-weighted MR imaging in rectal cancer: Comparison with single-shot echo-planar diffusion-weighted sequences.
Eur J Radiol,
2016,
85:1818-1823.
[8] Lee M A,
Cho S H,
Seo A N,
et al.
Modified 3-Point MRI-Based Tumor Regression Grade Incorporating DWI for Locally Advanced Rectal Cancer.
AJR Am J Roentgenol,
2017,
209:1247-1255.
[9] Sclafani F,
Brown G,
Cunningham D,
et al.
Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer.
Br J Cancer,
2017,
117:1478-1485.